Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David B Volkin

Showing results (31-40 of 175) with videos related to

Pageof 18
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|April 15, 2016
Production of Well-Characterized Virus-like Particles in an Escherichia coli-Based Expression Platform for Preclinical Vaccine AssessmentsNewton Wahome, Anne Cooper, Prem Thapa, et al.
Vaccines|October 26, 2024
Evaluating the Compatibility of Three Aluminum Salt-Adjuvanted Recombinant Protein Antigens (Trivalent NRRV) Combined with a Mock Trivalent Sabin-IPV Vaccine: Analytical and Formulation ChallengesPrashant Kumar, Atsushi Hamana, Christopher Bird, et al.
Journal of Pharmaceutical Sciences|March 27, 2012
An improved methodology for multidimensional high-throughput preformulation characterization of protein conformational stabilityNathaniel R Maddux, Ilan T Rosen, Lei Hu, et al.
Journal of Pharmaceutical Sciences|December 8, 2011
Formulation design and high-throughput excipient selection based on structural integrity and conformational stability of dilute and highly concentrated IgG1 monoclonal antibody solutionsAkhilesh Bhambhani, Julian M Kissmann, Sangeeta B Joshi, et al.
Journal of Pharmaceutical Sciences|July 28, 2006
Disassembly and reassembly of yeast-derived recombinant human papillomavirus virus-like particles (HPV VLPs)Henryk Mach, David B Volkin, Robert D Troutman, et al.
Biologicals : Journal of the International Association of Biological Standardization|July 6, 2014
Vaccine instability in the cold chain: mechanisms, analysis and formulation strategiesOzan S Kumru, Sangeeta B Joshi, Dawn E Smith, et al.
Molecular Pharmaceutics|March 5, 2016
Site-Specific Hydrolysis Reaction C-Terminal of Methionine in Met-His during Metal-Catalyzed Oxidation of IgG-1Olivier Mozziconacci, Jayant Arora, Ronald T Toth, et al.
Journal of Pharmaceutical Sciences|March 14, 2012
Biophysical characterization and stabilization of the recombinant albumin fusion protein sEphB4-HSAShuai Shi, Jing Liu, Sangeeta B Joshi, et al.
Advanced Drug Delivery Reviews|December 3, 2014
Formulation and stabilization of recombinant protein based virus-like particle vaccinesNishant K Jain, Neha Sahni, Ozan S Kumru, et al.
Journal of Pharmaceutical Sciences|January 3, 2014
Studies of the aggregation of RNase SaHarshit Khasa, Ryan Kramer, Nathan Maddux, et al.
Pageof 18

Showing results (31-40 of 175) with videos related to

Sort By:
Pageof 18
Methods in Molecular Biology (Clifton, N.J.)|April 15, 2016
Production of Well-Characterized Virus-like Particles in an Escherichia coli-Based Expression Platform for Preclinical Vaccine AssessmentsNewton Wahome, Anne Cooper, Prem Thapa, et al.
Vaccines|October 26, 2024
Evaluating the Compatibility of Three Aluminum Salt-Adjuvanted Recombinant Protein Antigens (Trivalent NRRV) Combined with a Mock Trivalent Sabin-IPV Vaccine: Analytical and Formulation ChallengesPrashant Kumar, Atsushi Hamana, Christopher Bird, et al.
Journal of Pharmaceutical Sciences|March 27, 2012
An improved methodology for multidimensional high-throughput preformulation characterization of protein conformational stabilityNathaniel R Maddux, Ilan T Rosen, Lei Hu, et al.
Journal of Pharmaceutical Sciences|December 8, 2011
Formulation design and high-throughput excipient selection based on structural integrity and conformational stability of dilute and highly concentrated IgG1 monoclonal antibody solutionsAkhilesh Bhambhani, Julian M Kissmann, Sangeeta B Joshi, et al.
Journal of Pharmaceutical Sciences|July 28, 2006
Disassembly and reassembly of yeast-derived recombinant human papillomavirus virus-like particles (HPV VLPs)Henryk Mach, David B Volkin, Robert D Troutman, et al.
Biologicals : Journal of the International Association of Biological Standardization|July 6, 2014
Vaccine instability in the cold chain: mechanisms, analysis and formulation strategiesOzan S Kumru, Sangeeta B Joshi, Dawn E Smith, et al.
Molecular Pharmaceutics|March 5, 2016
Site-Specific Hydrolysis Reaction C-Terminal of Methionine in Met-His during Metal-Catalyzed Oxidation of IgG-1Olivier Mozziconacci, Jayant Arora, Ronald T Toth, et al.
Journal of Pharmaceutical Sciences|March 14, 2012
Biophysical characterization and stabilization of the recombinant albumin fusion protein sEphB4-HSAShuai Shi, Jing Liu, Sangeeta B Joshi, et al.
Advanced Drug Delivery Reviews|December 3, 2014
Formulation and stabilization of recombinant protein based virus-like particle vaccinesNishant K Jain, Neha Sahni, Ozan S Kumru, et al.
Journal of Pharmaceutical Sciences|January 3, 2014
Studies of the aggregation of RNase SaHarshit Khasa, Ryan Kramer, Nathan Maddux, et al.
Pageof 18